Theseus Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
14 Feb 2024	Form 4: Yi Kathy, Director Disposed of 3,250 Restricted Stock Units (Disposition to Issuer) · Disposed of 99,634 Stock Option (Right to Buy) (Disposition to Issuer)
14 Feb 2024	Form 4: Stein Steven H, Director Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)
14 Feb 2024	Form 4: Orbimed Advisors Llc, Director and 2 others Disposed of 17,713,600 shares (Tender Offer)
14 Feb 2024	Form 4: Hayden Donald J Jr, Director Disposed of 10,000 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)
14 Feb 2024	Form 4: Gordon Carl L, Director Disposed of 17,713,600 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)
14 Feb 2024	Form 4: Dukes Iain D., Director Disposed of 388,324 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer) · Disposed of 441,959 Stock Option (Right to Buy) (Disposition to Issuer)
14 Feb 2024	Form 4: Dahms Bradford D., President and CFO Disposed of 8,150.225 shares (Tender Offer) · Disposed of 17,500 Restricted Stock Units (Disposition to Issuer) · Disposed of 332,114 Stock Option (Right to Buy) (Disposition to Issuer)
07 Nov 2023	Form 4: Shakespeare William, See Remarks Received 251,084 shares by exercise or conversion ($80.3K)
19 Jul 2023	Form 4: Gordon Carl L, Director Bought 479,932 shares ($1.46M)
19 Jul 2023	Form 4: Orbimed Advisors Llc, Director and 2 others Bought 479,932 shares ($1.46M)
19 Jul 2023	Form 4: Foresite Capital Management V, Llc, 10% owner and 4 others Bought 700,000 shares ($2.08M)
13 Jun 2023	Form 4: Stein Steven H, Director Granted 19,500 Stock Option (right to buy) · Granted 3,250 Restricted Stock Unit
13 Jun 2023	Form 4: Yi Kathy, Director Granted 19,500 Stock Option (right to buy) · Granted 3,250 Restricted Stock Unit
13 Jun 2023	Form 4: Hayden Donald J Jr, Director Granted 19,500 Stock Option (right to buy) · Granted 3,250 Restricted Stock Unit
13 Jun 2023	Form 4: Gordon Carl L, Director Granted 19,500 Stock Option (right to buy) · Granted 3,250 Restricted Stock Unit
13 Jun 2023	Form 4: Dukes Iain D., Director Granted 19,500 Stock Option (right to buy) · Granted 3,250 Restricted Stock Unit
02 Mar 2023	Form 4: Rivera Victor, Chief Scientific Officer Granted 16,250 Restricted Stock Units
02 Mar 2023	Form 4: Shakespeare William, See Remarks Granted 21,250 Restricted Stock Units
02 Mar 2023	Form 4: Kerstein David, Chief Medical Officer Granted 17,500 Restricted Stock Units
02 Mar 2023	Form 4: Dahms Bradford D., Chief Financial Officer Granted 17,500 Restricted Stock Units

Comments